Stockreport

Dianthus Therapeutics (DNTH) Is Up 30.8% After Upsized Raise And Early Phase 3 “Go” Decision [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF At the same time, the company announced an early “go” decision in its Phase 3 CAPTIVATE trial of claseprubart in CIDP, suggesting the drug's profile was strong enough t [Read more]